Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
Sidrah Khan, Caroline J. Rieser, Richard S. Hoehn, Samer Tohme, Ibrahim Nassour, David S. Medich, Amer H. Zureikat, Lindsay M. Sabik, Katherine Hrebinko
Publikováno v:
J Surg Res
Background Safety-net hospitals serve a vital role in society by providing care for vulnerable populations. Existing data regarding oncologic outcomes of patients with colon cancer treated at safety-net hospitals are limited and variable. The objecti
Autor:
Maxwell T. Trudeau, Fabio Casciani, Brett L. Ecker, Laura Maggino, Thomas F. Seykora, Priya Puri, Matthew T. McMillan, Benjamin Miller, Wande B. Pratt, Horacio J. Asbun, Chad G. Ball, Claudio Bassi, Stephen W. Behrman, Adam C. Berger, Mark P. Bloomston, Mark P. Callery, Carlos Fernandez-del Castillo, John D. Christein, Mary E. Dillhoff, Euan J. Dickson, Elijah Dixon, William E. Fisher, Michael G. House, Steven J. Hughes, Tara S. Kent, Giuseppe Malleo, Ronald R. Salem, Christopher L. Wolfgang, Amer H. Zureikat, Charles M. Vollmer
This study aims to present a full spectrum of individual patient presentations of pancreatic fistula risk, and to define the utility of mitigation strategies amongst some of the most prevalent, and vulnerable scenarios surgeons encounter.The FRS has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e4438f83dfe6550d15ddf10ccc735a
https://hdl.handle.net/11562/1086003
https://hdl.handle.net/11562/1086003
Autor:
Mordechai Rabinovitz, J. Wallis Marsh, Melissa E. Hogg, Asif Khalid, Rohit Das, Allan Tsung, Aatur D. Singhi, David A. Geller, Kenneth K.W. Lee, Kenneth E. Fasanella, James F. Pingpank, Abigail I. Wald, Michael A. Nalesnik, N. Paul Ohori, Adam Slivka, Amer H. Zureikat, Savreet Sarkaria, Randall E. Brand, Anil K. Dasyam, Jennifer Chennat, M. Samir Ayasso, David L. Bartlett, Nathan Bahary, Herbert J. Zeh, Marina N. Nikiforova, Abhinav Humar, Sara E. Monaco, Georgios I. Papachristou, Kevin McGrath
Publikováno v:
Gut. 69:52-61
ObjectiveDespite improvements in imaging, serum CA19-9 and pathological evaluation, differentiating between benign and malignant bile duct strictures remains a diagnostic conundrum. Recent developments in next-generation sequencing (NGS) have opened
Autor:
Anna E. Phillips, Harkirat Singh, Anil K. Dasyam, Kohtaro Ooka, Pedram Paragomi, Georgios I. Papachristou, Adam Slivka, Kenneth K. Lee, Amer H. Zureikat, Melissa Saul, Andrew D. Althouse, Dhiraj Yadav, Matthew G. Warndorf
Publikováno v:
Pancreatology
Background & aims The natural history of groove pancreatitis is incompletely characterized. Published literature suggests a high rate of surgery. We describe the short- and long-term outcomes in a cohort of patients with groove pancreatitis treated a
Autor:
David S. Medich, Jannat Malik, David A. Geller, Hamza O. Yazdani, Amer H. Zureikat, Christof Kaltenmeier, Samer Tohme
Publikováno v:
Am J Surg
Aim Surgery with or without chemotherapy represent the only curative option for patients with colon cancer. However, some patients refuse treatment despite the recommendation. This study aims to identify the incidence, risk factors and impact on surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::508b2708eeb788a7dd0056451eefa4b6
https://europepmc.org/articles/PMC7948090/
https://europepmc.org/articles/PMC7948090/
Autor:
Jeffrey Dueker, Abigail I. Wald, Amer H. Zureikat, David L. Bartlett, Marina N. Nikiforova, Vikram C. Gorantla, Nathan Bahary, James F. Pingpank, Christine Megerdichian Parseghian, John C. Rhee, Laura A. Favazza, Kenneth K.W. Lee, Somak Roy, Haroon A. Choudry, Cihan Kaya, Randall E. Brand, Alessandro Paniccia, Melanie Ongchin, Siobhan Proksell, Michael S. Landau, Aatur D. Singhi, Elyse Johnston
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Mutations in RAS occur in 30–50% of metastatic colorectal carcinomas (mCRCs) and correlate with resistance to anti-EGFR therapy. Consequently, mCRC biomarker guidelines state RAS mutational testing should be performed when considering EGFR inhibito
Autor:
Jennifer L. Miller-Ocuin, Michael T. Lotze, Melissa E. Hogg, Allan Tsung, Amer H. Zureikat, Pranav Murthy, Natalie Seiser, David L. Bartlett, Nathan Bahary, Lance A. Liotta, Brian A. Boone, Kenneth K. Lee, Herbert J. Zeh, Daolin Tang, Daniel P. Normolle, Aatur D. Singhi, Virginia Espina, J. Wallis Marsh, Ravi K. Amaravadi
Publikováno v:
Clin Cancer Res
Purpose: We hypothesized that autophagy inhibition would increase response to chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We performed a randomized controlled trial to assess the autophagy inhibitor hydroxych
Autor:
Herbert J. Zeh, Nathan Bahary, Amer H. Zureikat, Michael T. Lotze, Natalie Seiser, Amir A. Borhani, Brian A. Boone, Melissa E. Hogg, Mitchell Tublin, Alessandro Furlan, Rohit Dewan, Aatur D. Singhi
Publikováno v:
AJR Am J Roentgenol
OBJECTIVE. The goal of this study was to assess the correlation between CT-derived texture features of pancreatic ductal adenocarcinoma (PDAC) and histologic and biochemical markers of response to neoadjuvant treatment as well as disease-free surviva
Autor:
Dana H. Bovbjerg, Steven S. Ahrendt, Carissa A. Low, Matthew P. Holtzman, M. Haroon A. Choudry, David L. Bartlett, Amer H. Zureikat, Herbert J. Zeh, Heather L. Jones, Lekshmi Ramalingam, James F. Pingpank
Publikováno v:
Annals of Behavioral Medicine. 52:88-92
Background Postoperative ambulation is encouraged to promote timely recovery but is rarely monitored objectively or examined as a predictor of clinical outcomes, despite growing availability of wearable devices that allow passive quantification and r
Autor:
Kenneth K. Lee, James W. Marsh, Herbert J. Zeh, Melissa E. Hogg, Randall E. Brand, Georgios I. Papachristou, Kevin McGrath, David L. Bartlett, Marina N. Nikiforova, Adam Slivka, Sara E. Monaco, Allan Tsung, Kenneth E. Fasanella, James F. Pingpank, Abigail I. Wald, Anil K. Dasyam, Jennifer Chennat, Aatur D. Singhi, Amer H. Zureikat, N. Paul Ohori, Asif Khalid
Publikováno v:
Gut
ObjectiveDNA-based testing of pancreatic cyst fluid (PCF) is a useful adjunct to the evaluation of pancreatic cysts (PCs). Mutations in KRAS/GNAS are highly specific for intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (